You are here

Amgen

3 Charts Every Amgen Investor Needs to See

Motley Fool

Sun, 05/26/19 - 11:14 am

Mass exodus of Amgen sales reps sparks legal battle with multiple myeloma rival Karyopharm

Fierce Pharma

Fri, 05/24/19 - 04:35 pm

Karyopharm Therapeutics

Multiple Myeloma

Amgen offers $167m for drug discovery biotech Nuevolution

Pharmaforum

Wed, 05/22/19 - 10:52 am

Here's Why Mirati Therapeutics Is Surging Today

Motley Fool

Thu, 05/16/19 - 06:42 pm

Mirati Therapeutics

KRAS inhibitors

May 15 ASCO Quick Takes: After-hours pop for Iovance, MacroGenics; plus Takeda, Amgen, Forty Seven

BioCentury

Wed, 05/15/19 - 11:52 pm

cervical cancer

non-small cell lung cancer

HER2-positive metastatic breast cancer

How can Teva's migraine drug face off Amgen and Lilly? Put neurologists first, DTC last, executive says

Fierce Pharma

Tue, 05/14/19 - 04:55 pm

Teva Pharmaceutical

DTC advertising

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs

Yahoo/Benzinga

Sat, 05/11/19 - 12:31 pm

The Medicines Company

Lilly's new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions

Yahoo/Reuters

Sat, 05/11/19 - 12:10 pm

Teva Pharmaceutical

At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments

Xconomy

Sat, 05/4/19 - 04:54 pm

Teva Pharmaceutical

Amgen, Syapse enter precision medicine collaboration in oncology

Pharmaceutical Business Review

Fri, 05/3/19 - 10:46 am

precision medicine

Faint hope for Alder as Teva bucks dismal migraine trend

EP Vantage

Thu, 05/2/19 - 11:12 am

Alder Biopharmaceuticals

Key drugs Repatha, Aimovig flail as cheap copies eat into Amgen sales

Fierce Pharma

Tue, 04/30/19 - 08:52 pm

FDA Approves 19th Biosimilar, 2nd for Enbrel

RAPS.org

Fri, 04/26/19 - 07:38 pm

Samsung Bioepis

AstraZeneca dumps Amgen-partnered drug after midphase fail

Fierce Biotech

Fri, 04/26/19 - 11:46 am

Sjöogren’s syndrome

Feds say Astellas, Amgen will fork over $125M to settle charity kickback probes

Fierce Pharma

Thu, 04/25/19 - 06:49 pm

Pharma lobbyists flood the zone in D.C., with Pfizer and Amgen leading the way

Fierce Pharma

Wed, 04/24/19 - 10:47 pm

Consumer watchdog petitions FDA for black box warning on Amgen's Prolia

Fierce Pharma

Fri, 04/19/19 - 06:14 pm

spinal fractures

Amgen prices bone builder Evenity at $21,900/year to compete on convenience, not cost

Endpoints

Tue, 04/16/19 - 09:50 am

Upcoming events – a legal verdict for Enbrel and a clinical one for Cymabay

EP Vantage

Sat, 04/13/19 - 12:23 pm

FDA approves Evenity for osteoporosis

BioCentury

Tue, 04/9/19 - 07:03 pm

Pages